Pediatric DTC: which risk stratification system is best?

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • The American Thyroid Association (ATA) risk classification and dynamic risk stratification (DRS) systems are evaluated based on their associations with clinical outcomes.

Why this matters

  • Risk stratification aids postoperative treatment strategies, but the best classification system is unclear.

Key results

  • Both the ATA and DRS systems showed significant associations between risk classification and DFS (P<.001 for both).
  • Intermediate and low-risk patients had similar risk for recurrent/persistent disease (HR, 4.43; P=.161) in the ATA system.
  • High-risk patients had higher risk for recurrent/persistent disease (HR, 18.35; P=.005) compared with low-risk patients in the ATA system.
  • Indeterminate (HR, 10.20; P=.045) and structural incomplete (HR, 98.68; P<.001) patients had increased risk for recurrent/persistent disease based on response to initial therapy in the DRS system.

Study design

  • 77 pediatric patients with differentiated thyroid cancer (DTC) who underwent thyroid surgery were assessed for clinical outcomes and associations with ATA and DRS risk groups.
  • Funding: Asan Institute for Life Sciences.

Limitations

  • Retrospective study.
  • Small patient sample size.